La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Healwell AI Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Healwell AI ha un patrimonio netto totale di CA$63.2M e un debito totale di CA$15.0M, che porta il suo rapporto debito/patrimonio netto a 23.8%. Le sue attività totali e le sue passività totali sono rispettivamente CA$93.4M e CA$30.2M.

Informazioni chiave

23.8%

Rapporto debito/patrimonio netto

CA$15.02m

Debito

Indice di copertura degli interessi	n/a
Contanti	CA$19.82m
Patrimonio netto	CA$63.17m
Totale passività	CA$30.21m
Totale attività	CA$93.38m

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CA$36.3M ) di 6H90 superano le sue passività a breve termine ( CA$12.7M ).

Passività a lungo termine: Le attività a breve termine di 6H90 ( CA$36.3M ) superano le sue passività a lungo termine ( CA$17.5M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 6H90 ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di 6H90 si è ridotto da 66.9% a 23.8% negli ultimi 5 anni.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: 6H90 ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: 6H90 ha una liquidità sufficiente per 1.2 anni se il flusso di cassa libero continua a ridursi ai tassi storici del 50.4 % ogni anno.

Healwell AI Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

New minor risk - Financial position

Second quarter 2024 earnings released

Healwell AI Inc. to Report Q2, 2024 Results on Aug 12, 2024

Healwell AI Inc. (TSX:AIDX) acquired 20% stake in Mci Polyclinic Group Inc.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of VeroSource Solutions Inc.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc. announced that it has received CAD 20.00025 million in funding

First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.14 loss in 1Q 2023)

Healwell AI Inc. to Report Q1, 2024 Results on May 14, 2024

Healwell AI Inc. announced that it expects to receive CAD 16.000065 million in funding

Healwell AI Inc., Annual General Meeting, Jun 25, 2024

Healwell AI Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.56 loss per share (vs CA$0.42 loss in FY 2022)

Healwell AI Inc. to Report Q4, 2023 Results on Mar 28, 2024

Healwell AI Inc. Announces Executive Changes

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

New major risk - Shareholder dilution

Healwell AI Inc. has completed a Composite Units Offering.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of an unknown majority stake in Pentavere Research Group Inc. Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire an unknown stake in Pentavere Research Group Inc. for CAD 5.9 million.

Third quarter 2023 earnings released: CA$0.14 loss per share (vs CA$0.18 loss in 3Q 2022)

Healwell Ai Inc. Appoints Mark Findlay as Senior Vice President of Sales and Marketing for Canada

Healwell AI Inc. to Report Q3, 2023 Results on Nov 15, 2023

Healwell AI Inc. announced that it has received CAD 3.00024 million in funding

Less than half of directors are independent

Healwell Al Inc. Announces Board and Executive Changes

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. Announces Sven Grail and George Christodoulou, the Former Co-Chairs, Did Not Stand for Re-Election

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: CA$0.21 loss per share (vs CA$0.084 loss in 2Q 2022)

MCI Onehealth Technologies Inc., Annual General Meeting, Sep 21, 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

MCI Onehealth Technologies Inc. announced that it has received CAD 1.5 million in funding

First quarter 2023 earnings released: CA$0.15 loss per share (vs CA$0.086 loss in 1Q 2022)

MCI Onehealth Technologies Inc. Announces Changes to Management Team Structure

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

MCI Onehealth Technologies Inc. Expands Data Insights Offering with Innovative AI-driven Continuing Medical Education

Second quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.058 loss in 2Q 2021)

MCI Onehealth Technologies Inc. to Report Q2, 2022 Results on Aug 15, 2022

MCI Onehealth Technologies Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.054 loss in 1Q 2021)

MCI Onehealth Technologies Inc. to Report Q1, 2022 Results on May 16, 2022

Less than half of directors are independent

MCI Onehealth Technologies Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CA$0.33 loss per share (vs CA$0.027 loss in FY 2020)

MCI Onehealth Technologies Inc. Provides Revenue Guidance for Fiscal 2022

MCI Onehealth Appoints Jennifer Foster as Chief Operating Officer with Mandate to Support Expansion of Tech and Data Offerings

Third quarter 2021 earnings released: CA$0.11 loss per share

Co-Founder & Co-Executive Chair recently bought €58k worth of stock

Second quarter 2021 earnings released

MCI Onehealth Technologies Inc. (TSX:DRDR) acquired a 9% stake in ReGen Scientific Inc.

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Analisi della pista di contanti

Scoprire le aziende sane